NewCo News: Del Mar Pharma Bets on Glioblastoma Salvage Therapy

CeNeRx Hits Phase II Home Stretch with $13M Series C

NewCo News: Valocor says 'Beat It' to Acne, Atopic Dermatitis and Vitiligo

Dicerna Raises $25M Series B to Fund RNAi Cancer Program

Tetralogic Coasts into Clinic with $32M Financing

NewCo News: Sirnaomics Takes Multitarget Approach to Gene Silencing

Trius' IPO Low Like Others, but Window Could Be Near

NewCo News: Senex Targets Aging Diseases with CKI Pathway Inhibitors